(Q44660604)

5 December 2017

title

Decreased survival in EGFR gene amplified vulvar carcinoma (English)

1 reference

5 December 2017

9

Darrell R Borger

1 reference

5 December 2017

8

A John Iafrate

1 reference

5 December 2017

5

Dora C Dias-Santagata

1 reference

5 December 2017

4

Esther Oliva

1 reference

5 December 2017

Whitfield B Growdon

1

1 reference

5 December 2017

Susan L Boisvert

2

1 reference

5 December 2017

Sara Akhavanfard

3

1 reference

5 December 2017

Sakiko Kojiro

6

1 reference

5 December 2017

Neil S Horowitz

7

1 reference

5 December 2017

Bo R Rueda

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

3 September 2008

1 reference

5 December 2017

1 reference

5 December 2017

volume

111

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

289-297

1 reference

5 December 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

7 January 2021

Carcinoma of the vulva

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

EGFR antagonists in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Who will benefit from treatment against EGFR?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

ErbB-targeted therapeutic approaches in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Epidermal growth factor receptor tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

EGFR FISH versus mutation: different tests, different end-points.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Cofactors with human papillomavirus in a population-based study of vulvar cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Trends in the incidence of invasive and in situ vulvar carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Detection of PCR products using self-probing amplicons and fluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Mode of action and application of Scorpion primers to mutation detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Targeting the epidermal growth factor receptor in high-grade astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2008.07.038

1 reference

release_6rk2hteiyfawzdkoxsajow6qpi

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6rk2hteiyfawzdkoxsajow6qpi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference